Recent insider trading activity from Smith Andrew Alasdair, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Medicus Pharma Ltd. | $MDCX | Smith Andrew Alasdair | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,029,144 | 9999.99% | 0.23% |
| Dec. 16, 2025 | Medicus Pharma Ltd. | $MDCX | Smith Andrew Alasdair | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,029,144 | 9999.99% | 0.23% |